Randomised comparison of femoral versus radial approach for percutaneous coronary intervention using abciximab in acute myocardial infarction: Results of the FARMI Trial

Heart

Volumn 93, Issue 12, 2007, Pages 1556-1561

  Brasselet, Camille ^a   Tassan, Sophie ^a   Nazeyrollas, Pierre ^a   Hamon, Martial ^b   Metz, Damien ^a  

^a SERVICE DE DERMATOLOGIE   (France)

^b CAEN UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ABCIXIMAB; ACETYLSALICYLIC ACID; CLOPIDOGREL; ENOXAPARIN; HEPARIN;

ACUTE HEART INFARCTION; ADULT; ANGIOCARDIOGRAPHY; ARTERY DISEASE; ARTICLE; BLEEDING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEMOGRAPHY; FEMALE; FLUOROSCOPY; HOSPITALIZATION; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT DURATION; TREATMENT OUTCOME;

ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; ANTIBODIES, MONOCLONAL; ANTICOAGULANTS; COMBINED MODALITY THERAPY; FEMALE; HUMANS; IMMUNOGLOBULIN FAB FRAGMENTS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PLATELET AGGREGATION INHIBITORS; PROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 36749024012     PISSN: 13556037     EISSN: None     Source Type: Journal    
DOI: 10.1136/hrt.2007.117309     Document Type: Article

References (27)

1. Weaver WD, Simes RJ, Betriu A, et al. Comparison of primary coronary angioplasty and intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review. JAMA 1997;278:2093-8.
2. Grines CL, Cox DA, Stone GW, the Stent Primary Angioplasty in Myocardial Infarction Study Group, et al. Coronary angioplasty with or without stent implantation for acute myocardial infarction. N Engl J Med 1999;341:1949-56.
3. Tcheng JE, Kandzari DE, Grines CL, CADILLAC investigators, et al. Benefits and risks of abxicimab use in primary angioplasty for acute myocardial infarction: the Controlled Abxicimab and Device Investigation to Lower Late Angioplasty Complications (CADILLAC) Trial. Circulation 2003;108:1316-23.
4. Brasselet C, Metz D, Perotin S, et al. Direct stent implantation without predilatation through 5 French guiding catheter following transfemoral coronary angiogram: a feasibility study. Catheter Cardiovasc Interv 2003;60:354-9.
5. Hamon M, Sabotier R, Zhao Q, et al. Mini-invasive strategy in acute coronary syndromes: direct coronary stenting using 5Fr guiding catheters and transradial approach. Cathet Cardiovasc Interv 2002;55:340-3.
6. Agostoni P, Biondi-Zoccai GG, de Benedictis ML, et al. Radial versus femoral approach for percutaneous coronary diagnostic and interventional procedures: systematic overview and meta-analysis of randomised trials. J Am Coll Cardiol 2004;44:349-56.
7. Cox N, Resnic FS, Popma JJ, et al. Comparison of the risk of vascular complications associated with femoral and radial access coronary catheterization procedures in obese versus nonobese patients. Am J Cardiol 2004;94:1174-7.
8. Ludman PF, Stephens NG, Harcombe A, et al. Radial versus femoral approach for diagnostic coronary angiography in stable angina pectoris. Am J Cardiol 1997;79:1239-41.
9. McFadden E, Hamon M. Radial access, compression techniques, and complications in: Trans-radial approach for radial interventions. ESM editions 2003.
10. Montalescot G, Andersen HR, Antoniucci D, et al. Summary of recommendations on percutaneous coronary intervention for the reperfusion of acute ST elevation myocardial infarction. Heart 2004;90:676-7.
11. Ryan TJ, Faxon DP, Gunnar RM, et al. Guidelines for percutaneous transluminal coronary angioplasty. A report of the American College of Cardiology/American Heart Association Task Force on Assessment of Diagnostic and Therapeutic Cardiovascular Procedures (Subcommittee on Percutaneous Transluminal Coronary Angioplasty). Circulation 1988;78:486-502.
12. Wallentin L, Goldstein P, Armstrong PW, et al. Efficacy and safety of tenecteplase in combination with the low-molecular-weight heparin enoxaparin or unfractionated heparin in the prehospital setting: the Assessment of the Safety and Efficacy of a New Thrombolytic Regimen (ASSENT)-3 PLUS randomized trial in acute myocardial infarction. Circulation 2003;108:135-42.
13. Cantor WJ, Puley G, Natarajan MK, et al. Radial versus femoral access for emergent percutaneous coronary intervention with adjunct glycoprotein IIb/IIIa inhibition in acute myocardial infarction - the RADIAL-AMI pilot randomized trial. Am Heart J 2005;150:543-49.
14. Gobeil F, Bruck M, Louvard Y, et al. Comparison of 5 French versus 6 French guiding catheters for transradial coronary intervention: a prospective, randomized study. J Invasive Cardiol 2004;16:353-5.
15. Lotan C, Hasin Y, Mosseri M, et al. Transradial approach for coronary angiography and angioplasty. Am J Cardiol 1995;76:164-7.
16. Mann T, Cubeddu G, Bowen J, et al. Stenting in acute coronary syndromes: a comparison of radial versus femoral access sites. J Am Coll Cardiol 1998;32:572-6.
17. Louvard Y, Benamer H, Garot P, for the OCTOPLUS study group, et al. Comparison of transradial and transfemoral approaches for coronary angiography and angioplasty in octogenarians (the OCTOPLUS study). Am J Cardiol 2004;94:1177-80.
18. Choussat R, Black A, Bossi I, et al. Vascular complications and clinical outcome after coronary angioplasty with platelet IIb/IIIa receptor blockade. Comparison of transradial and transfemoral arterial access. Eur Heart J 2000;21:607-9.
19. Louvard Y, Ludwig J, Lefevre T, et al. Transradial approach for coronary angioplasty in the setting of acute myocardial infarction: a dual-center registry. Cathet Cardiovasc Interv 2002;55:206-11.
20. Philippe F, Larrazet F, Meziane T, et al. Comparison of transradial versus transfemoral approach of acute myocardial infarction with primary angioplasty and abciximab. Cathet Cardiovasc Interv 2004;61:67-73.
21. Ziakas A, Klinke P, Mildenberger R, et al. Comparison of the radial and the femoral approaches in percutaneous coronary intervention for acute myocardial infarction. Am J Cardiol 2003;91:598-600.
22. Saito S, Tanaka S, Hiroe Y, et al. Comparative study on transradial approach versus transfemoral approach in primary stent implantation for patients with acute myocardial infarction: results of the test for myocardial infarction by prospective unicenter randomisation for access site (TEMPURA) trial. Cathet Cardiovasc Interv 2003;59:26-33.
23. Gobeil F, Bruck M, Louvard Y, et al. Comparison of 5 French versus 6 French guiding catheters for transradial coronary intervention: a prospective, randomized study. J Invasive Cardiol 2004;16:353-5.
24. Petronio AS, Musumecci G, Limbruno U, et al. Abxicimab improves 6-month clinical outcome after rescue coronary angioplasty. Am Heart J 2002;143:334-41.
25. Montalescot G, Barragan P, Wittenberg O, ADMIRAL Investigators, et al. Platelet glycoprotein IIIb/IIIa inhibition with coronary stenting for acute myocardial infarction: ADMIRAL investigators. N Engl J Med 2001;344:1895-903.
26. de Queiroz Fernandas Araujo JO, Veloso HH, De Paiva JMB, et al. Efficacy and safety of abciximab on myocardial infarction treated with percutaneous coronary interventions: a meta-analysis of randomised controlled trials. Am Heart J 2004;148:937-43.
27. Hanlon JT, Combs DT, Mc Lellan BA, et al. Early hospital discharge after direct angioplasty for acute myocardial infarction. Cathet Cardiovasc Diagn 1995;35:187-90.